Skip to content

Medical-device intelligence

NYO: Autoantibodies, Anti-Ribonucleic Acid Polymerase (Rnap) Iii Antibody

FDA product code NYO: Autoantibodies, Anti-Ribonucleic Acid Polymerase (Rnap) Iii Antibody. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
NYO
FDA device name
Autoantibodies, Anti-Ribonucleic Acid Polymerase (Rnap) Iii Antibody
Device class
2
Regulation number
866.5100
Medical specialty
Immunology
Review panel
IM

FDA definition

The anti-rna polymerase iii test is a semi-quantitative elisa for the detection of anti-rna polymerase iii antibodies in human serum. The test result is used as an aid in the diagnosis of systemic sclerosis (ssc) in conjunction with the clinical and other laboratory findings. For in-vitro diagnostic use.
Explore immunology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

4 clearance records and 0 recall records in the covered releases, across 4 source company names and 1 product codes. Dated history runs from Jun 19, 2006 to Sep 13, 2021.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

4 matching records
Device / recordCompany in FDA recordSourceSource date
EliA RNA Pol IIIK202541 · NYOPhadia AB510(k)Sep 13, 2021FDA decision date
ImmuLisa Enhanced RNA POL III Antibody ELISAK172078 · NYOImmco Diagnostics, Inc.510(k)Mar 30, 2018FDA decision date
QUANTA LITE RNA POL III ELISAK070066 · NYOInova Diagnostics, Inc.510(k)Apr 11, 2007FDA decision date
ANTI RNA POLYMERASE III ELISA KIT, MODEL 7805K060431 · NYOMbl International Corporation510(k)Jun 19, 2006FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗